Expanding orders for cosmetics OEM manufacturing and securing production-line utilization
First written in FY2016. 6 of 9 entries say "Restated". Latest entry: FY2019-Q2.
2 other companies' latest entry also says "Restated".
- FY2019-Q2RestatedAnnual report
「With respect to the "Cosmetics" segment reported during the second quarter of the previous fiscal year, 日本レース株式会社 manufactured and sold cosmetics, quasi-drugs and other products. Following the transfer of all shares in the company held by the Company on 29 September 2017, the Group exited the cosmetics business.」
Reconfirms the exit from the cosmetics OEM business following the transfer of shares in 日本レース株式会社 as a basis for the segment change. - FY2019-Q1RestatedAnnual report
「With respect to the "Cosmetics" segment reported during the first quarter of the previous fiscal year, 日本レース株式会社 manufactured and sold cosmetics, quasi-drugs and other products. Following the transfer of all shares in the company held by the Company on 29 September 2017, the Group exited the cosmetics business.」
Reconfirms the exit from the cosmetics business following the transfer of shares in 日本レース株式会社 as a basis for the decline in revenue and the segment change. - FY2018RestatedAnnual report
「On 29 September 2017, the Company transferred all shares of 日本レース株式会社 that it held, and the Group withdrew from the cosmetics business.」
Reconfirms the exit from the cosmetics OEM business through the transfer of shares in 日本レース株式会社. - FY2018-Q3RestatedAnnual report
「On 29 September 2017, the Company transferred all shares of 日本レース株式会社 that it held, and the Group withdrew from the cosmetics business.」
Reiterates that the company has exited the cosmetics OEM business. - FY2018-Q2DroppedAnnual report
「As a result, from the second quarter of the current consolidated fiscal year, 日本レース株式会社 was excluded from the scope of consolidation, and the Group withdrew from the cosmetics business.」
The Group withdrew from the cosmetics OEM business by transferring all shares of 日本レース株式会社, which operated the cosmetics business. - FY2017-Q3RestatedAnnual report
「In the cosmetics business, orders for all-in-one serums, dental-related products and dog shampoo remained strong from the previous year, but orders for amenity products declined. Consequently, revenue decreased 3.8% year on year to ¥193.820 million, while operating profit decreased 8.7% to ¥18.834 million.」
Strong orders for major products continued, but lower orders for amenity products reduced revenue and operating profit in the cosmetics business as a whole. - FY2017-Q2AdvancedAnnual report
「In the cosmetics business, the Company manufactures cosmetics and quasi-drugs on an OEM basis. Orders for all-in-one serums and hotel amenity products remained strong from the previous year and increased, but fewer orders for dental-related products than usual led to a 6.6% year-on-year decrease in revenue to ¥126.820 million and a 24.4% decrease in operating profit to ¥8.605 million.」
OEM orders for all-in-one serums and hotel amenities increased, but lower orders for dental-related products reduced revenue and operating profit for the business as a whole. - FY2017-Q1RestatedAnnual report
「In the cosmetics business, OEM orders for all-in-one serums and full-body serums remained at normal seasonal levels. Revenue decreased 6.1% year on year to ¥64.629 million, while operating profit decreased 0.5% to ¥6.418 million.」
Cosmetics OEM orders continued, but remained at normal seasonal levels in the current quarter, with no specific progress reported in expanding orders. - FY2016First statedAnnual report
「The Company will strengthen and enforce equipment and quality control while actively marketing to existing and new OEM customers. In addition to integrated manufacturing covering production, filling and finishing, it will actively accept orders for finishing-only work to keep the lines fully utilized.」
The Company is seeking to improve utilization by combining quality control, sales to existing and new OEM customers, integrated manufacturing and finishing-process orders.